These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26607062)

  • 1. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Wilkoff BL; Fauchier L; Stiles MK; Morillo CA; Al-Khatib SM; Almendral J; Aguinaga L; Berger RD; Cuesta A; Daubert JP; Dubner S; Ellenbogen KA; Mark Estes NA; Fenelon G; Garcia FC; Gasparini M; Haines DE; Healey JS; Hurtwitz JL; Keegan R; Kolb C; Kuck KH; Marinskis G; Martinelli M; McGuire M; Molina LG; Okumura K; Proclemer A; Russo AM; Singh JP; Swerdlow CD; Teo WS; Uribe W; Viskin S; Wang CC; Zhang S
    Heart Rhythm; 2016 Feb; 13(2):e50-86. PubMed ID: 26607062
    [No Abstract]   [Full Text] [Related]  

  • 2. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Wilkoff BL; Fauchier L; Stiles MK; Morillo CA; Al-Khatib SM; Almendral J; Aguinaga L; Berger RD; Cuesta A; Daubert JP; Dubner S; Ellenbogen KA; Estes NA; Fenelon G; Garcia FC; Gasparini M; Haines DE; Healey JS; Hurtwitz JL; Keegan R; Kolb C; Kuck KH; Marinskis G; Martinelli M; Mcguire M; Molina LG; Okumura K; Proclemer A; Russo AM; Singh JP; Swerdlow CD; Teo WS; Uribe W; Viskin S; Wang CC; Zhang S;
    Europace; 2016 Feb; 18(2):159-83. PubMed ID: 26585598
    [No Abstract]   [Full Text] [Related]  

  • 3. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
    Heart Rhythm; 2020 Jan; 17(1):e220-e228. PubMed ID: 31103461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL;
    Europace; 2019 Sep; 21(9):1442-1443. PubMed ID: 31090914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
    J Interv Card Electrophysiol; 2020 Oct; 59(1):135-144. PubMed ID: 31960345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Wilkoff BL; Fauchier L; Stiles MK; Morillo CA; Al-Khatib SM; Almendral J; Aguinaga L; Berger RD; Cuesta A; Daubert JP; Dubner S; Ellenbogen KA; Estes NA; Fenelon G; Garcia FC; Gasparini M; Haines DE; Healey JS; Hurtwitz JL; Keegan R; Kolb C; Kuck KH; Marinskis G; Martinelli M; McGuire M; Molina LG; Okumura K; Proclemer A; Russo AM; Singh JP; Swerdlow CD; Teo WS; Uribe W; Viskin S; Wang CC; Zhang S
    J Arrhythm; 2016 Feb; 32(1):1-28. PubMed ID: 26949427
    [No Abstract]   [Full Text] [Related]  

  • 7. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
    J Arrhythm; 2019 Jun; 35(3):485-493. PubMed ID: 31293697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
    Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troubleshooting implantable cardioverter-defibrillator sensing problems II.
    Swerdlow CD; Asirvatham SJ; Ellenbogen KA; Friedman PA
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):212-20. PubMed ID: 25691555
    [No Abstract]   [Full Text] [Related]  

  • 10. NICE guidelines for use of implantable cardioverter defibrillators.
    Saberwal B; Ahsan S
    Br J Hosp Med (Lond); 2015 Jun; 76(6):316-7. PubMed ID: 26053899
    [No Abstract]   [Full Text] [Related]  

  • 11. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wilkoff BL, et al. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Europace; 2017 Apr; 19(4):580. PubMed ID: 28431075
    [No Abstract]   [Full Text] [Related]  

  • 13. Overcoming the defects of a virtue: dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Sweeney MO
    Circulation; 2006 Jun; 113(25):2862-4. PubMed ID: 16801472
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy and safety of implantable cardioverter defibrillator avoiding routine defibrillation threshold testing].
    Liu Q; Zhou S; Qi S; Zeng G; Ma X; Huang H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1132-5. PubMed ID: 19952404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE.
    Hernández-Madrid A; Paul T; Abrams D; Aziz PF; Blom NA; Chen J; Chessa M; Combes N; Dagres N; Diller G; Ernst S; Giamberti A; Hebe J; Janousek J; Kriebel T; Moltedo J; Moreno J; Peinado R; Pison L; Rosenthal E; Skinner JR; Zeppenfeld K;
    Europace; 2018 Nov; 20(11):1719-1753. PubMed ID: 29579186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of ventricular interval during atrial fibrillation by atrioventricular node vagal stimulation: chronic clinical atrioventricular-nodal stimulation download study.
    Bianchi S; Rossi P; Schauerte P; Elvan A; Blomström-Lundqvist C; Kornet L; Gal P; Mörtsell D; Wouters G; Gemein C
    Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):562-8. PubMed ID: 25878323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
    Moss AJ
    Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293
    [No Abstract]   [Full Text] [Related]  

  • 18. Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes.
    Priori SG; Wilde AA; Horie M; Cho Y; Behr ER; Berul C; Blom N; Brugada J; Chiang CE; Huikuri H; Kannankeril P; Krahn A; Leenhardt A; Moss A; Schwartz PJ; Shimizu W; Tomaselli G; Tracy C
    Heart Rhythm; 2013 Dec; 10(12):e85-108. PubMed ID: 23916535
    [No Abstract]   [Full Text] [Related]  

  • 19. Troubleshooting implanted cardioverter defibrillator sensing problems I.
    Swerdlow CD; Asirvatham SJ; Ellenbogen KA; Friedman PA
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1237-61. PubMed ID: 25516582
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of supraventricular arrhythmias on the outcomes of guideline-compliant implantable cardioverter defibrillator programming.
    Teerawongsakul P; Ananwattanasuk T; Chokesuwattanaskul R; Shah M; Lathkar-Pradhan S; Barham W; Oral H; Thakur RK; Jongnarangsin K; Tanawuttiwat T
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):794-801. PubMed ID: 38384108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.